1 |
Kim DH, Kim HM, Ryu JH, UM JY, Kim SC, Y JH, Cho MK, Yim JP, Hong SH. Herbal Pharmacology. Seoul:Shin-Il books. 2001:242-6.
|
2 |
Bae JH, Lee MJ, Lee SM. Antimicrobial Effect of Cutellaria baicalensis Geroge Extracts on Food-Borne Pathogens. J Microbiol Biotechnol. 2005;33:35-40.
|
3 |
Trinh HT, Han SJ, Kim SW, Lee YC, Kim DH. Bifidus fermentation increases hypolipidemic and hypoglycemic effects of red ginseng. J Microbiol Biotechnol. 2007;17:1127-33.
|
4 |
Lee SI, Shin JG, Kim SD. Effect of ginsengchungkukjang effects on lipid profiles of serum in alcohol administered diabeticinduced rats. J Korean Soc Food Sci Nutr. 2005b;34:1362-6.
DOI
ScienceOn
|
5 |
Cha JY, Park JC, Ahn HY, Eom KE, Park BK, Jun BS, Lee CH, Cho YS. Effect of Monascus purpureus-Fermented Korean Red Ginseng Powder on the Serum Lipid Levels and Antioxidative Activity in Rats. J Korean Soc Food Sci Nutr. 2009;38:1153-60.
DOI
ScienceOn
|
6 |
Tsukahara M, Shinzato N, Tamaki Y, Namihira T, Matsui T. Red yeast rice fermentation by selected Monascus sp.with deep-red color, lovastatin production but no citrinin, and effect of temperature-shift cultivation on lovastatin production. Appl Biochem Biotechnol. 2009;158:476-82.
DOI
ScienceOn
|
7 |
Pyo YH, Lee TC. The potential antioxidant capacity and angiotensin I-converting enzyme inhibitory activity of Monascus-fermented soybean extracts:evaluation of Monascusfermented soybean extracts as multifunctional food additives. J Food Sci. 2007;72:S218-23.
DOI
ScienceOn
|
8 |
KFDA. Toxicity Study Criteria of medicine and medical supplies. Seoul. KFDA. notification No. 2009-116. 2009.
|
9 |
Organization for Economic Co-Operation and Development (Ed.). OECD guideline (423) for testing of chemicals - acute oral toxicity-acute toxic class method. 2001.
|
10 |
Irwin S. Comprehensive observational assessment: Ia. A systemic, quantitative procedure for assessing the behavioral and physiological state of the mouse. Psychopharmacology. 1968;13:222-57.
DOI
ScienceOn
|
11 |
Dourish CT. Effects of drugs on spontaneous motor activity. In: Experimental Psychopharmacology. Greenshaw AJ, Dourish CT, Ed. Clifton:Humana Press. 1987:325-34.
|
12 |
Kim IR, Kim HC, Kook YB, Park SJ, Park YG, Park JH, Seo BI, Seo YB, Song HJ, Shin MK, Lee YJ, Lee YC, Lee JH, Yim KH, Cho SI, Jeong JG, Joo YS, Choi HY. Herbology. Seoul:Younglim.2007;216-18.
|
13 |
Blach-Olszewska Z, Jatczak B, Rak A, Lorenc M, Gulanowski B, Drobna A, Lamer-Zarawska E. Production of cytokines and stimulation of resistance to viral infection in human leukocytes by Scutellaria baicalensis flavones. J Interferon Cytokine Res. 2008;28:571-81.
DOI
ScienceOn
|
14 |
Waisundara VY, Hsu A, Huang D, Tan BK. Scutellaria baicalensis enhances the antidiabetic activity of metforminin streptozotocin-induced diabetic Wistar rats. Am J Chin Med. 2008;36:517-40.
DOI
ScienceOn
|
15 |
Sun X, Chan LN, Gong X, Sucher NJ Nmethyl-D-aspartate receptor antagonist activity in traditional Chinese stroke medicines. Neurosignals. 2003;12:31-8.
DOI
ScienceOn
|
16 |
Udut EV, Zhdanov VV, Gur'iantseva LA, Minakova MIu, Dygai AM. Mechanisms of the erythropoiesis-stimulating effect of skullcap (Scutellaria baicalensis) extract. Eksp Klin Farmakol. 2005;68:43-5.
|
17 |
Przybylska D, Dlugosz A. The research on Antoxid activity in free radicals processes. Acta Pol Pharm. 2007;64:491-5.
|
18 |
Himeji M, Ohtsuki T, Fukazawa H, Tanaka M, Yazaki S, Ui S, Nishio K, Yamamoto H, Tasaka K, Mimura A. Difference of growthinhibitory effectof Scutellaria baicalensisproducing flavonoid wogonin among human cancercells and normaldiploidcell. Cancer Lett. 2007;245:299-74.
|
19 |
Wang JY, Chuang HN, Chiu JH, Fu SL, Tsai TH, Tsou AP, Hu CP, Chi CW, Yeh SF, Lui WY, Wu CW, Chou CK. Effects of Scutellariabaicalensis Georgi on macrophagehepatocyte interaction through cytokines related to growth control of murine hepatocytes. Exp Biol Med(Maywood). 2006;231:444-55.
DOI
|
20 |
Huang ST, Lee Y, Gullen EA, Cheng YC. Impacts of baicalein analogs with modification of the 6th position of A ring on the activity toward NF-kappaB-, AP-1-, or CREBmediated transcription. Bioorg Med Chem Lett. 2008b;18:5046-9.
DOI
ScienceOn
|
21 |
Mehendale S, Aung H, Wang CZ, Tong R, Foo A, Xie JT, Yuan CS. Scutellaria baicalensis and a constituent flavonoid, baicalein, attenuate ritonavir-induced gastrointestinal side-effects. J Pharm Pharmacol. 2007;59:1567-72.
DOI
ScienceOn
|
22 |
Lee BH, Lee SJ, Kang TH, Kim DH, Sohn DH, Ko GI, Kim YC. Baicalein: an in vitro antigenotoxic compound from Scutellaria baicalensis. Planta Med. 2000;66:70-1.
|
23 |
Lee JW, Jung YS, Jung TY, Kim JD, Choi HY. Mouse Single Oral Dose Toxicity Test of Scutellariae Radix Aqueous Extracts. Korean J Orient Int Med. 2013;34:46-59.
DOI
ScienceOn
|
24 |
Yimam M, Zhao Y, Ma W, Jia Q, Do SG, Shin JH. 90-day oral toxicity study of UP446, a combination of defined extracts of Scutellaria baicalensis and Acacia catechu, in rats. Food Chem Toxicol. 2010;48:1202-9.
DOI
ScienceOn
|
25 |
Chang BY, Malla B, Sohn DH, Kim YC, Kim SY. Acute Toxicity of a Combined Preparation of the Standardized Extracts of Scutellaria baicalensis GEORGI and Salvia miltiorrhiza BUNGE. Kor J Pharmacogn. 2011;42:295-70.
|
26 |
Plata EJ, Murphy WH. Growth and haematologic properties of the BALB/wm strain of inbred mice. Lab Anim Sci. 1972;22:712-20.
|
27 |
Yamaguchi C, Fujita S, Obara T, Ueda T. Effects of room temperature on reproduction, body weight and organ weights, food and water intakes, and hematology in mice. Exp Anim. 1983;32:1-11.
DOI
|
28 |
Lee JH, Yang KJ, Shin HD, Park BR, Son CW, Jang HJ, Park DC, Lee HS, Ku SK. Single subcutaneous dose toxicity of Polycan(R), a -glucan originated from Aureobasidium in mice. Lab Anim Res. 2005a;21:299-305.
|
29 |
Lee HS, Lee IG, Ku SK. Single oral dose toxicity study of water extracts of Picrorrhiza Rhizoma in mice. J Toxicol Pub Health. 2006;22:117-29.
|
30 |
Banks WJ. Female reproductive system. In: Banks WJ, ed. Applied veterinary histology, 2nd ed. Baltimore:Williams & Wilkins. 1988:506-29.
|
31 |
US Enviromental Protection Agency Health Effects Test Guidelines OPPTS 870.100. Acute Toxicity Testing Backround. US EPA August. Washington. USA. 1998.
|